3SBio Inc. Announces Unaudited Second Quarter 20...( SHENYANG China Aug. 11 Asia-First...),Health

SHENYANG, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the second quarter ended June 30, 2009.

    Second Quarter 2009 Financial Highlights:
    -- Total net revenues increased by 36.8% over the second quarter of 2008
       to RMB81.5 million (US$11.9 million).
    -- Operating income increased by 69.9% over the second quarter of 2008 to
       RMB25.8 million (US$3.8million) on a GAAP basis, and increased by 60.1%
       over the second quarter of 2008 to RMB27.1 million (US$4.0 million) on
       a non-GAAP basis.
    -- Net income increased by 39.2% over the second quarter of 2008 to
       RMB27.0 million (US$4.0 million) on a GAAP basis, and increased by
       26.3% over the second quarter of 2008 to RMB26.7 million
       (US$3.9 million) on a non-GAAP basis.
    -- Net income per American Depositary Share ("ADS") for the second quarter
       of 2009 was RMB1.25 (US$0.18) compared with RMB0.89 (US$0.13) for the
       second quarter of 2008 on a GAAP basis, and  RMB1.24 (US$0.18) for the
       second quarter of 2009 compared with RMB0.97 (US$0.14) for the second
       quarter of 2008 on a non-GAAP basis.


    First Half 2009 Financial Highlights:
    -- Total net revenues increased by 30.5% over the first half of 2008 to
       RMB150.1 million (US$22.0 million).
    -- Operating income increased by 56.3% over the first half of 2008 to
       RMB 45.9 million (US$6.7 million) on a GAAP basis, and increased by
       51.1% to RMB 47.7 million (US$7.0 million) on a non-GAAP basis.
    -- Net income increased by 9.5% over the first half of 2008 to
       RMB42.9 million (
'/>"/>
SOURCE  3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
Related medicine news :

1. 3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009
2. 3SBio Inc. Announces Unaudited First Quarter 2009 Results
3. 3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP
4. 3SBio Inc. Announces Filing of Annual Report on Form 20-F
5. 3SBio Inc. to Present at The CIBC World Markets 18th Annual Healthcare Conference
6. Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results
7. Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors
8. Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
9. Leading Medical Developer Announces Plans for Texoma Medical Plaza
10. iMedX Announces Investment of $13M From RFE Investment Partners
11. Health Market Science Announces Commercial Release of CompleteSpend V2.5